RECENT NEWS

Eppendorf has announced the commercial launch of the SpinPro 6 R centrifuge, the first in the new range of SpinPro floor-standing and benchtop centrifuges.

Scientists at Duke-NUS Medical School have found that viruses circulating in live poultry markets can be detected more effectively by sampling the surrounding environment than by testing individual birds.

A new international research effort is underway to find the best ways to protect babies from respiratory syncytial virus (RSV), a common infection of the nose, throat and lungs that can cause serious breathing problems in young children.

AI pathology firm PathAI has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to PathAssist Derm, designed to analyse digital pathology whole slide images (WSIs) of skin lesions and aid pathologists in their review.

Leica Biosystems streamlines multiplex immunofluorescence (IF) for oncology and translational research with the launch of its BOND 4-Plex Fluorescent Detection Kit for research use only.

Rapid testing for bacterial infections is being rolled out in community pharmacies and GP surgeries across Wales.

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, have announced a three-year collaboration aimed at better understanding why inflammatory bowel disease (IBD) runs in some Saudi families, and how that knowledge can lead to risk ascertainment, earlier diagnosis and more personalised treatment options.

Coronaviruses not only use the machinery of the human cells they infect; they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly.

AI-powered digital diagnostics company Techcyte has announced that its Fusion AP platform has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR).

Thermo Fisher Scientific has introduced the Fluid Ease Pro ClipTip electronic pipette which includes the first large, high-resolution pipette touchscreen on the market, as well as intelligent power management and advanced programming capabilities.

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports.

DNA sequencing and array-based technology firm Illumina has unveiled a suite of advancements that will accelerate the next era of genomic discovery.

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

Point-of-care diagnostic firm BHR Biosynex has appointed Adam Martin as Country Manager for the UK and Ireland.

Epredia and Mindpeak have announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.

In a significant advancement for cancer immunotherapy, researchers have developed a novel approach using mRNA-encoded nanobodies that effectively combat colorectal cancer in preclinical models.

Cancer diagnostics firm GRAIL has announced the topline results from the landmark, randomised, controlled NHS-Galleri trial, which evaluated annual multi-cancer screening with the Galleri blood test in the NHS over three years in 142,000 demographically representative participants aged 50 to 77.

A new research paper has shown the first evidence of a WHO ‘critical priority’ fungal pathogen becoming more deadly when co-infected with tuberculosis.

Researchers from the University of Southern Denmark have identified a new virus in a common gut bacterium. The virus is found significantly more often in patients with colorectal cancer.

Researchers in Imperial’s Fleming Initiative have been awarded £3 million of new funding through a global programme to help transform the discovery of new antibiotics and tackle the growing threat of antimicrobial resistance (AMR).